http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1517881_PMID31585275

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440136918_AID1517881_PMID31585275_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103250040_AID1517881_PMID31585275_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104234145_AID1517881_PMID31585275_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440150198_AID1517881_PMID31585275_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440166587_AID1517881_PMID31585275_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440176995_AID1517881_PMID31585275_VALUE6
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08183
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Reversal of P-gp mediated multidrug resistance in human HepG2/Dox cells assessed as potentiation of doxorubicin-induced cell growth inhibition at 10 uM measured after 48 hrs by MTT assay (Rvb = 24%)
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440176995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440150198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103250040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104234145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440136918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440166587
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1517881

Total number of triples: 17.